Journal of Experimental & Clinical Cancer Research

Table 3 Clinical characteristic of patients with TNBC and DNBC patient cohort for PCR-array screening profile and plasma qRT-PCR validation lot

From: Aberrant miRNAs expressed in HER-2 negative breast cancers patient

No	TNM stage	Age
PCR-array plasma
TNBC
1	T4bN3M0	58
2	T2 N1 M0	47
3	T3N2M0	59
4	T4bN1 M0	51
5	T3 N1 M0	45
6	T4bN2M0	51
7	T2 N1 M0	51
8	T2 N1 M0	56
9	T4bN2M0	43
10	T2 N1 M0	35
11	T2N2Mx	53
12	T2 N1 M0	40
13	T4cN2Mx	59
14	T4bN2M0	55
15	T1N0M0	48
16	T1 N1 M0	56
17	T2N2Mo	54
18	T4bN2Mx	40
19	T2N0M0	52
20	cT2 N1 M0	59
DPBC
1	T2N2M0	54
2	T2N2M0	52
3	T4bN2Mx	72
4	T4bN2M0	62
5	T3 N1 M0	62
6	T2N1Mx	52
7	T2N1Mo	51
8	T2 N1 M0	45
9	T3N0Mx	43
10	T3 N1 M0	57
11	T2N0M0	48
12	T1N0M0	56
13	T4aN0M0	53
14	T2N0M0	62
qRT-PCR plasma
TNBC
1	T4bN1 M0	56
2	T2N0M0	59
3	T2N3cM0	58
4	T2 N1 M0	57
5	T2 N1 M0	46
6	T2N0M0	53
7	cT2N2M0	59
8	T4bN2M0	73
9	cT1N0M0	70
10	T2N2Mx	49
11	cT4bN2M0	61
12	cT4bN2Mx	57
13	cT2N1Mx	74
14	T2N0M0	53
15	T2N0M0	34
16	T2N1cM0	62
17	T4bN2M0	46
18	T1 N1 M0	38
19	T3 N1 M0	40
20	T2 N1 M0	35
21	T2N0M0	36
22	T2N0M0	37
23	T2N0M0	34
24	T2N0M0	36
DPBC
1	T2 N1 M0	54
2	T2NoMo	59
3	T2 N1 M0	52
4	T2N0M0	46
5	T4bN2Mx	60
6	T3N1Mx	63
7	T2N0M0	67
8	T4bN2M0	53
9	T3N1Mx	43
10	T2N0M0	51
11	T2 N1 M0	64
12	T2N1Mo	57
13	T4bN2M0	45
14	T3N0Mx	69
15	T2N1Mx	52
16	T2 N1 M0	44
17	T2 N1 M0	55
18	T2 N1 M0	62
19	T1 N1 M0	49
20	T3N1Mx	40
21	T3N0Mx	45
22	T3N1Mx	60
23	T4N2M0	63
24	T4 N1 M0	50
25	T2N1Mx	65
26	T2 N1 M0	60
27	T2NoMo	44
28	T4bN2Mo	47

Back to article page

ISSN: 1756-9966

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com